Search results
Results from the WOW.Com Content Network
There is an association between rheumatoid factor and more persistently active synovitis, more joint damage, greater eventual disability and arthritis. [12] [13] Other than in rheumatoid arthritis, rheumatoid factor may also be elevated in other conditions, including: Systemic lupus erythematosus (SLE) [14] [15] Sjögren syndrome [14] [15]
Tenosynovial giant cell tumor (TGCT) is a non-malignant tumor defined histologically as inclusions of “osteoclast-like” multinucleated giant cells, hemosiderin, and macrophages. [1] This histology can present one of 2 clinically distinct ways. TGCT tumors often develop from the lining of joints (also known as synovial tissue).
Anti-rheumatoid factor antibodies are also increased. [95] In addition, cross-reactive anti-beef-collagen antibodies (IgG) may explain some rheumatoid arthritis (RA) incidences. [ 96 ] Although the presence of anti-beef collagen antibodies does not necessarily lead to RA, the RA association with Triticeae consumption is secondary to GSE and ...
For instance, in rheumatoid arthritis, an autoimmune disease primarily affecting the joints, symptoms typically include joint pain, swelling, and stiffness. On the other hand, type 1 diabetes, which results from an autoimmune attack on the insulin-producing cells of the pancreas, primarily presents with symptoms related to high blood sugar ...
Oxidative DNA damages cause both mutations [51] and epigenetic alterations. [52] [46] [53] RNS also cause mutagenic DNA damages. [54] A normal cell may undergo carcinogenesis to become a cancer cell if it is frequently subjected to DNA damage during long periods of chronic inflammation. DNA damages may cause genetic mutations due to inaccurate ...
[5] [8] Risk factors include a family history of the condition and having another autoimmune disease. [3] Diagnosis is confirmed with blood tests for TSH, Thyroxine (T 4), antithyroid autoantibodies, and/or ultrasound. [3] Other conditions that can produce similar symptoms include Graves' disease and nontoxic nodular goiter. [6]
Treatment is guided by the severity and specific cause of the disease. Treatment focuses on eliminating the underlying problem, whether that means discontinuing drugs suspected to cause it or treating underlying sepsis. Diagnosis and treatment of serious thrombocytopenia is usually directed by a hematologist.
[29]: 5 [6] A genetic factor is believed to contribute, but there is no single gene known to be responsible for increased risk. Instead, many gene variants probably have a small individual effect, but their combined effect can be strong. [13] Other factors may include problems with the nervous and immune systems, as well as energy metabolism. [12]